Carvacrol as an Antimicrobial Adjuvant in Complementary Therapy for Infectious Diseases: A Mini-Review
Keywords:
Antimicrobial resistance, biofilm, carvacrol, combination therapy, essential oilAbstract
The rapid emergence of multidrug-resistant microorganisms has reduced the effectiveness of conventional antimicrobial therapy and intensified the search for alternative and complementary anti-infective strategies. Carvacrol, a naturally occurring phenolic monoterpenoid predominantly found in essential oils of Origanum and Thymus species, has attracted considerable attention because of its broad-spectrum antimicrobial and resistance-modifying properties. This mini-review summarizes the antimicrobial mechanisms of carvacrol and evaluates its potential as a complementary agent in infectious disease therapy. Carvacrol primarily targets the microbial cytoplasmic membrane, where its lipophilic nature facilitates membrane incorporation, perturbs lipid organization, increases permeability, and promotes leakage of ions and intracellular constituents. Its proton-exchange activity contributes to dissipation of the transmembrane pH gradient and proton motive force, resulting in impaired ATP generation and cellular homeostasis. In addition to direct antibacterial activity, carvacrol exhibits antibiofilm, antifungal, and antiviral properties through multiple mechanisms. Of particular therapeutic interest is its ability to enhance the activity of conventional antimicrobials. Experimental studies demonstrate synergistic or additive interactions with agents including polymyxin B, erythromycin, cefixime, ceftazidime, cefepime, and selected antifungal drugs, although outcomes vary according to the microorganism, antimicrobial, and experimental conditions. Carvacrol-rich essential oils have also demonstrated promising antimicrobial combinations, but their effects should be distinguished from those of purified carvacrol. Despite encouraging in vitro and preclinical evidence, limited pharmacokinetic information, formulation challenges, potential toxicity at therapeutic concentrations, and insufficient clinical validation currently restrict translation. Further standardized mechanistic, formulation, animal, and clinical studies are therefore required to establish carvacrol as a safe and effective antimicrobial adjuvant.
References
Al-Tawalbeh, D., Alkhawaldeh, Y., Sawan, H. M., Al-Mamoori, F., Al-Samydai, A., & Mayyas, A. (2024). Assessment of carvacrol-antibiotic combinations’ antimicrobial activity against methicillin-resistant Staphylococcus aureus. Frontiers in Microbiology, 14, 1349550. https://doi.org/10.3389/fmicb.2023.1349550
Asadi, S., Nayeri-Fasaei, B., Zahraei-Salehi, T., Yahya-Rayat, R., Shams, N., & Sharifi, A. (2023). Antibacterial and anti-biofilm properties of carvacrol alone and in combination with cefixime against Escherichia coli. BMC Microbiology, 23(1), 55. https://doi.org/10.1186/s12866-023-02797-x
Bădescu, B., Buda, V., Romanescu, M., Lombrea, A., Danciu, C., Dalleur, O., Dohou, A. M., Dumitraşcu, V., Creţu, O., Licker, M., & Muntean, D. (2022). Current state of knowledge regarding WHO critical priority pathogens: Mechanisms of resistance and proposed solutions through candidates such as essential oils. Plants, 11(14), 1789. https://doi.org/10.3390/plants11141789
Cordeiro, L. V., Figueiredo, P. T. R. de, Sousa, A. P. de, Júnior, F. P. de A., Souza, H. D. da S., Araújo, D. L., Sobreira, A. L. de C., & Lima, E. de O. (2020). Association of carvacrol with ceftazidime and cefepime against Klebsiella pneumoniae. Research, Society and Development, 9(7). https://doi.org/10.33448/rsd-v9i7.4089
Fadli, M., Saad, A., Sayadi, S., Chevalier, J., Mezrioui, N.-E., Pagès, J.-M., & Hassani, L. (2012). Antibacterial activity of Thymus maroccanus and Thymus broussonetii essential oils against nosocomial infection-bacteria and their synergistic potential with antibiotics. Phytomedicine, 19(5), 464–471. https://doi.org/10.1016/j.phymed.2011.12.003
Fermiano, T. H., Souza, J. V. P. de, Murase, L. S., Pasquini, J. P. S., Scodro, R. B. de L., Campanerut-Sá, P. A. Z., Caleffi-Ferracioli, K. R., Siqueira, V. L. D., Meneguello, J. E., Teixeira, J. J. V., & Cardoso, R. F. (2024). Antimicrobial activity of carvacrol and its derivatives on Mycobacterium spp.: Systematic review of preclinical studies. Future Medicinal Chemistry, 16(7), 679–688. https://doi.org/10.4155/fmc-2023-0249
Fimbres-García, J. O., Flores-Sauceda, M., Othón-Díaz, E. D., García-Galaz, A., Tapia-Rodríguez, M. R., Silva-Espinoza, B. A., & Ayala-Zavala, J. F. (2022). Facing resistant bacteria with plant essential oils: Reviewing the oregano case. Antibiotics, 11(12), 1777. https://doi.org/10.3390/antibiotics11121777
Fimbres-García, J. O., Flores-Sauceda, M., Othón-Díaz, E. D., García-Galaz, A., Tapia-Rodríguez, M. R., Silva-Espinoza, B. A., Álvarez-Armenta, A., & Ayala-Zavala, J. F. (2024). Lippia graveolens essential oil to enhance the effect of imipenem against axenic and co-cultures of Pseudomonas aeruginosa and Acinetobacter baumannii. Antibiotics, 13(5), 444. https://doi.org/10.3390/antibiotics13050444
Friedman, M. (2014). Chemistry and multibeneficial bioactivities of carvacrol (4-isopropyl-2-methylphenol), a component of essential oils produced by aromatic plants and spices. Journal of Agricultural and Food Chemistry, 62(31), 7652–7670. https://doi.org/10.1021/jf5023862
Gan, C., Langa, E., Wang, G., Bambeke, F. V., Ballestero, D., & Pino-Otín, M. R. (2025). Mechanisms of action and resistance prevention of synergistic thymol and carvacrol combinations with antibiotics in Staphylococcus aureus and Acinetobacter baumannii. Natural Products and Bioprospecting, 15(1), 36. https://doi.org/10.1007/s13659-025-00518-7
Imran, M., Aslam, M., Alsagaby, S. A., Saeed, F., Ahmad, I., Afzaal, M., Arshad, M. U., Abdelgawad, M. A., El-Ghorab, A. H., Khames, A., Shariati, M. A., Ahmad, A., Hussain, M., Imran, A., & Islam, S. (2022). Therapeutic application of carvacrol: A comprehensive review. Food Science & Nutrition, 10(11), 3544–3561. https://doi.org/10.1002/fsn3.2994
Jánosity, A., Baranyi, J., Surányi, B. B., Možina, S. S., Taczman-Brückner, A., Kiskó, G., & Klančnik, A. (2023). Estimating the optimal efflux inhibitor concentration of carvacrol as a function of the bacterial physiological state. Frontiers in Microbiology, 14, 1073798. https://doi.org/10.3389/fmicb.2023.1073798
Kachur, K., & Suntres, Z. E. (2019). The antibacterial properties of phenolic isomers, carvacrol and thymol. Critical Reviews in Food Science and Nutrition, 60(18), 3042–3053. https://doi.org/10.1080/10408398.2019.1675585
Khan, I., Bahuguna, A., Kumar, P., Bajpai, V. K., & Kang, S. C. (2017). Antimicrobial potential of carvacrol against uropathogenic Escherichia coli via membrane disruption, depolarization, and reactive oxygen species generation. Frontiers in Microbiology, 8, 2421. https://doi.org/10.3389/fmicb.2017.02421
Khan, M., Khan, S. T., Khan, M., Mousa, A. A., Mahmood, N., & Alkhathlan, H. Z. (2019). Chemical diversity in leaf and stem essential oils of Origanum vulgare L. and their effects on microbicidal activities. AMB Express, 9(1), 176. https://doi.org/10.1186/s13568-019-0893-3
Magi, G., Marini, E., & Facinelli, B. (2015). Antimicrobial activity of essential oils and carvacrol, and synergy of carvacrol and erythromycin, against clinical, erythromycin-resistant group A streptococci. Frontiers in Microbiology, 6, 165. https://doi.org/10.3389/fmicb.2015.00165
Marchese, A., Arciola, C. R., Coppo, E., Barbieri, R., Barreca, D., Chebaibi, S., Sobarzo-Sánchez, E., Nabavi, S. F., Nabavi, S. M., & Daglia, M. (2018). The natural plant compound carvacrol as an antimicrobial and anti-biofilm agent: Mechanisms, synergies and bio-inspired anti-infective materials. Biofouling, 34(6), 630–656. https://doi.org/10.1080/08927014.2018.1480756
Mediouni, S., Jablonski, J. A., Tsuda, S., Barsamian, A., Kessing, C., Richard, A., Biswas, A., Toledo, F., Andrade, V. M., Even, Y., Stevenson, M., Tellinghuisen, T., Choe, H., & Valente, S. T. (2020). Oregano oil and its principal component, carvacrol, inhibit HIV-1 fusion into target cells. Journal of Virology, 94(15), e00147-20. https://doi.org/10.1128/JVI.00147-20
Mączka, W., Twardawska, M., Grabarczyk, M., & Wińska, K. (2023). Carvacrol—A natural phenolic compound with antimicrobial properties. Antibiotics, 12(5), 824. https://doi.org/10.3390/antibiotics12050824
Romanescu, M., Oprean, C., Lombrea, A., Bădescu, B., Teodor, A., Constantin, G.-D., Andor, M., Folescu, R., Muntean, D., Danciu, C., Dalleur, O., Batrina, S. L., Creţu, O., & Buda, V. (2023). Current state of knowledge regarding WHO high priority pathogens—Resistance mechanisms and proposed solutions through candidates such as essential oils: A systematic review. International Journal of Molecular Sciences, 24(11), 9727. https://doi.org/10.3390/ijms24119727
Shaban, S., Patel, M., & Ahmad, A. (2020). Improved efficacy of antifungal drugs in combination with monoterpene phenols against Candida auris. Scientific Reports, 10(1), 1162. https://doi.org/10.1038/s41598-020-58203-3
Souza, G. H. de A. de, Radai, J. A. S., Vaz, M. S. M., Silva, K. E. da, Fraga, T. L., Barbosa, L. S., & Simionatto, S. (2021). In vitro and in vivo antibacterial activity assays of carvacrol: A candidate for development of innovative treatments against KPC-producing Klebsiella pneumoniae. PLoS ONE, 16(2), e0246003. https://doi.org/10.1371/journal.pone.0246003
Suntres, Z. E., Coccimiglio, J., & Alipour, M. (2013). The bioactivity and toxicological actions of carvacrol. Critical Reviews in Food Science and Nutrition, 55(3), 304–318. https://doi.org/10.1080/10408398.2011.653458
Ultee, A., Bennik, M. H. J., & Moezelaar, R. (2002). The phenolic hydroxyl group of carvacrol is essential for action against the food-borne pathogen Bacillus cereus. Applied and Environmental Microbiology, 68(4), 1561–1568. https://doi.org/10.1128/aem.68.4.1561-1568.2002
Wijesundara, N. M., Lee, S. F., Cheng, Z., Davidson, R., & Rupasinghe, H. P. V. (2021). Carvacrol exhibits rapid bactericidal activity against Streptococcus pyogenes through cell membrane damage. Scientific Reports, 11(1), 1487. https://doi.org/10.1038/s41598-020-79713-0
Zhang, D., Gan, R., Ge, Y., Yang, Q., Ge, J., Li, H., & Corke, H. (2018). Research progress on the antibacterial mechanisms of carvacrol: A mini review. Bioactive Compounds in Health and Disease, 1(6), 71–78. https://doi.org/10.31989/bchd.v1i6.551
GBD 2021 Antimicrobial Resistance Collaborators. (2024). Global burden of bacterial antimicrobial resistance 1990–2021: A systematic analysis with forecasts to 2050. The Lancet, 404, 1199–1226. https://doi.org/10.1016/S0140-6736(24)01867-1
Murray, C. J. L., Ikuta, K. S., Sharara, F., Swetschinski, L., Aguilar, G. R., Gray, A., Han, C., Bisignano, C., Rao, P., Wool, E., Johnson, S. C., Browne, A. J., Chipeta, M. G., Fell, F., Hackett, S., Haines-Woodhouse, G., Hamadani, B. H. K., Kumaran, E. A. P., McManigal, B., ... Naghavi, M. (2022). Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. The Lancet, 399(10325), 629–655. https://doi.org/10.1016/S0140-6736(21)02724-0
World Health Organization. (2024). WHO bacterial priority pathogens list, 2024: Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. World Health Organization.
World Health Organization. (2025). Global antibiotic resistance surveillance report 2025. World Health Organization.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Journal of Applied Animal Biosciences
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
